20181017-安永-When_the_human_body_is_the_biggest_data_platform,_how_will_medtech_companies_capture_value__62页_9mb

Summary of "When the human body is the biggest data platform, how will medtech companies capture value?"

Core Content

This document explores the evolving landscape of the medical technology (medtech) industry in the context of the Fourth Industrial Revolution, emphasizing the shift from product-centric to data-centric value creation. It highlights the growing role of data and analytics in driving innovation and improving health outcomes, and the urgent need for medtech companies to adapt their business models and invest in digital capabilities to remain competitive.

Main Points

• Data as the New Value Driver:
  The human body is becoming the largest data platform, and medtech companies must transition from focusing on products to leveraging data and analytics to create value. Data will be the engine of future growth, enabling personalized, real-time care management.

• Shift to Patient-Centric Models:
  The industry is moving toward a patient-centric approach, where digital platforms facilitate seamless care delivery. This shift is driven by consumer demand for more personalized and proactive health management, as well as the increasing sophistication of data tools used by providers and payers.

• Rising Consumer Expectations:
  Patients are now more empowered and demand greater involvement in their health care. Wearables, sensors, and digital interfaces are critical tools for enabling this shift, and providers are using data to improve clinical insights and care efficiency.

• Challenges from Tech Sector:
  Technology companies, with significant financial resources and expertise in digital platforms, are entering the health care space and challenging traditional medtech players. These new entrants are developing data-rich solutions that could disrupt the market if medtech companies fail to adapt.

• Digital Transformation in Medtech:
  The report outlines the early signs of digital transformation, including the integration of artificial intelligence (AI) in imaging and surgical devices, and the use of algorithms for diagnostic purposes. These innovations are reshaping care delivery and creating new opportunities for value creation.

Key Findings

• Short-Term Focus:
  Medtech companies are overemphasizing short-term growth and shareholder returns, often at the expense of long-term R&D investment. This creates an "innovation gap" and risks long-term sustainability.

• R&D Investment Decline:
  R&D spending growth has slowed significantly over the past decade, from an average of 15.5% in 2000-07 to 4.7% in 2013-17. In 2017, medtech companies spent more on share buybacks and dividends than on R&D, raising concerns about future innovation capacity.

• M&A Trends:
  M&A activity in 2017-18 was relatively modest compared to previous years, with fewer large deals and a greater focus on tuck-in acquisitions to build scale in therapeutic areas. However, the lack of significant digital acquisitions suggests a gap in the industry's transformation efforts.

• Regulatory and Market Pressures:
  Payers are increasingly demanding evidence of value from new medical devices and tests, pushing the industry toward outcome-based reimbursement models. This requires medtech companies to develop data-driven solutions that demonstrate real-world impact.

• Need for Strategic Investment:
  Medtech leaders must rethink their business models to focus on data-centric innovation and create agile, end-to-end services that align with the needs of all stakeholders in the health ecosystem. This includes not only providers and payers but also consumers who seek personalized health solutions.

Key Recommendations

• Medtech companies should prioritize investments in digital capabilities and data analytics to stay competitive.
• There is a need to shift from product-centric to outcome-centric value creation, aligning with the growing importance of personalized care.
• Strategic M&A should focus on acquiring digital skills and capabilities, not just expanding product portfolios.
• The industry must address the innovation gap by increasing R&D investment and fostering a culture of long-term strategic thinking.

Conclusion

The medtech industry is at a pivotal moment, with data and analytics becoming central to its future. Companies that fail to adapt their business models and invest in digital transformation may be left behind as new entrants from the tech sector gain ground. The focus must shift from short-term gains to long-term value creation through data-driven, patient-centric solutions.